Sabeti Mohammad, Black Natalie, Ramazani Mohsen, Zarenejaddivkolahei Nafiseh, Moosazadeh Mahmood
Advanced Specialty Program in Endodontics, UCSF School of Dentistry, 707 Parnassus Ave. Room-D 3226, San Francisco, CA 94143, USA.
UCSF Advanced Specialty Program in Endodontics, 707 Parnassus Ave. Room-D 3226, San Francisco, CA 94143, USA.
Dent J (Basel). 2025 Feb 20;13(3):91. doi: 10.3390/dj13030091.
Guided tissue regeneration (GTR) and the use of various grafting materials and platelet concentrates have emerged as promising adjunctive techniques in endodontic surgery to enhance bone regeneration and improve healing outcomes, although evidence regarding their consistent effectiveness remains inconclusive. The aim of this systematic review is to evaluate existing randomized controlled trials (RCTs) and prospective clinical trials to determine the efficacy of bone grafts, membranes, or platelet concentrates on outcomes in endodontic periapical surgery, employing a robust evidence-based approach. : Searches were conducted in MEDLINE (PubMed), Embase, Cochrane Library, and gray literature databases from their inception until March 2024. Study selection and data extraction were conducted independently by two reviewers. Eligible randomized controlled trials (RCTs) and prospective clinical trials underwent critical appraisal for risk of bias and quality of evidence and were subjected to meta-analysis to determine treatment effects. : Twelve studies were included. The pool success rate for periapical surgery using any regenerative material (bone graft, membrane, or platelet concentrate) was 2.48 (OR: 2.48, 95% CI: 1.42-4.34). Multiple subgroup analyses based on the type of regenerative material used during treatment were performed, presenting high certainty of evidence. The subgroup analysis, which examined bone graft only, bone graft with membrane, membrane only, concentrated growth factor only, and concentrated growth factor with bone graft, yielded significant results only for concentrated growth factor with bone graft (OR: 15.01, 95% CI: 1.12-271.70). While the success rate of periapical surgery with other regenerative materials did not reach statistical significance, the effect size was substantial. Overall, the findings indicate that utilizing a concentrated growth factor with a bone graft significantly improves the success of bone regeneration procedures over a 12-month follow-up period compared to interventions without these components. However, more research will be needed with larger sample sizes and longer follow-up times.
引导组织再生(GTR)以及各种移植材料和血小板浓缩物的使用,已成为牙髓手术中有前景的辅助技术,以促进骨再生并改善愈合结果,尽管关于它们持续有效性的证据仍不明确。本系统评价的目的是评估现有的随机对照试验(RCT)和前瞻性临床试验,采用强有力的循证方法,以确定骨移植、膜或血小板浓缩物对牙髓根尖手术结果的疗效。检索在MEDLINE(PubMed)、Embase、Cochrane图书馆和灰色文献数据库中进行,从建库至2024年3月。研究选择和数据提取由两名评价员独立进行。符合条件的随机对照试验(RCT)和前瞻性临床试验接受了偏倚风险和证据质量的严格评价,并进行荟萃分析以确定治疗效果。纳入了12项研究。使用任何再生材料(骨移植、膜或血小板浓缩物)进行根尖手术的总体成功率为2.48(比值比:2.48,95%可信区间:1.42 - 4.34)。基于治疗期间使用的再生材料类型进行了多项亚组分析,证据确定性高。仅检查骨移植、骨移植加膜、仅膜、仅浓缩生长因子以及浓缩生长因子加骨移植的亚组分析,仅浓缩生长因子加骨移植产生了显著结果(比值比:15.01,95%可信区间:1.12 - 271.70)。虽然使用其他再生材料进行根尖手术的成功率未达到统计学显著性,但效应量很大。总体而言,研究结果表明,与没有这些成分的干预措施相比,在12个月的随访期内,使用浓缩生长因子加骨移植显著提高了骨再生程序的成功率。然而,需要更大样本量和更长随访时间的更多研究。